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Autophagy can either antagonize or promote intracellular bacterial growth, depending
on the pathogen. Here, we investigated the role of autophagy during a pulmonary
infection with the obligate intracellular pathogen, Chlamydia pneumoniae (CP). In
mouse embryonic fibroblasts (MEFs) or macrophages, deficiency of autophagy pathway
components led to enhanced CP replication, suggesting that autophagy exerts a
bactericidal role. However, in vivo, mice with myeloid-specific deletion of the autophagic
protein ATG16L1 suffered increased mortality during CP infection, neutrophilia, and
increased inflammasome activation despite no change in bacterial burden. Induction of
autophagy led to reduced CP replication in vitro, but impaired survival in CP-infected
mice, associated with an initial reduction in IL-1β production, followed by enhanced
neutrophil recruitment, defective CP clearance, and later inflammasome activation and
IL-1β production, which drove the resulting mortality. Taken together, our data suggest
that a delicate interplay exists between autophagy and inflammasome activation in
determining the outcome of CP infection, perturbation of which can result in inflammatory
pathology or unrestricted bacterial growth.
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INTRODUCTION
Autophagy, the process by which cellular material is recycled (1), has been increasingly found to
play a central role in diverse diseases and pathologies (2). One key role for autophagy is the removal
of damaged mitochondria (3), termed mitophagy, which in turn can modulate inflammatory
processes by dampening activation of the nucleotide binding domain and leucine-rich repeat (NLR)
pyrin domain containing 3 (NLRP3) inflammasome (4–8). Thus, loss of autophagic function can
lead to enhanced inflammation via greater NLRP3 inflammasome activation and secretion of IL-1β.
Release of this pro-inflammatory cytokine is tightly regulated, because although IL-1β is critical
in controlling many microbial infections, over production can lead to enhanced pathology and
chronic inflammation (9, 10).
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In addition to regulating cytokine production, autophagy
can play a direct role in microbial clearance in a process
known as xenophagy (11). This is particularly important for
intracellular bacteria such as Salmonella typhimurium, group A
Streptococcus, and Mycobacterium tuberculosis. In these cases,
the autophagic phagophore forms around the invading bacteria,
and the resulting autophagosome is targeted for fusion with
the lysosome (12–14). Bacteria can escape this eradication by
actively preventing lysosomal fusion (15, 16), or autophagy
induction and/or elongation (17). A related process that uses
many components of the autophagosome machinery, termed
LC3 associated phagocytosis (LAP), targets the production of
reactive oxygen species in the phagosome lumen to directly kill
bacteria such as S. typhimurium and Burkholderia pseudomallei
(18, 19). Finally, some bacterial agents can co-opt components
of the autophagosomal machinery in order to survive and
replicate (20, 21).
CP is an obligate intracellular bacterium that mainly infects
macrophages and neutrophils, and exists in an inclusion inside
the cell (22). While CP infection is thought to be responsible
for up to 10–20% of cases of community-acquired pneumonia
(23), it has also been associated with many chronic inflammatory
diseases including atherosclerosis, Alzheimer’s disease, and
asthma (24). CP have a unique lifecycle whereby they exist as
an infectious elementary body (EB), which enters the host cell
and forms an inclusion (22). Once inside, it changes into the
metabolically active reticulate body (RB) and replicates inside
the inclusion (22). Eventually RBs revert to the EB state and
burst forth from the cell (22). While CP inclusions do not
fuse with the lysosome, lysosomal maturation seems to be a
requirement for CP growth (25), raising the possibility that the
autophagy pathway plays a role in either preventing or facilitating
CP infection.
In this study we found blocking autophagy led to increased CP
growth in both macrophages and mouse embryonic fibroblasts.
In vivo, loss of the autophagy elongation component ATG16L1
specifically in myeloid cells led to increased mortality in response
to CP infection, characterized by greater numbers of neutrophils
and dendritic cells, but no change in the CP burden in the
lungs. This was accompanied by an increase in inflammasome-
active macrophages and IL-1β production. While induction of
autophagy in macrophages led to reduced CP growth in vitro,
in vivo treatment with rapamycin led to increased mortality
of infected mice, likely due to initial impairment in IL-1β
production resulting in increased bacterial load.
MATERIALS AND METHODS
Mice and Cell Lines
C57BL/6 (wild-type [WT]) mice were purchased from Jackson
Labs (Bar Harbor,ME) and then bred in the Cedars-SinaiMedical
Center Comparative Medicine facility. Atg16l1fl/fl Lysmcre mice
were obtained from Dr. David Shih, Cedars-Sinai medical Center
(26). Atg16l1fl/fl mice were used as littermate controls. Eight-
to ten-weeks-old female mice were used in all experiments in
this study. WT, Atg16l1+/−, and Atg5−/− mouse embryonic
fibroblasts (MEF)s were obtained from Dr. Jae Jung (University
of Southern California) (27) and grown in DMEM media
containing 10% FBS. In some cases, 1µg/ml cycloheximide
(Sigma Aldrich, St. Louis MO), MEM amino acids (Sigma
Aldrich, St. Louis MO), or Na-pyruvate (Sigma Aldrich, St. Louis
MO) were added to the media. Atg5fl/fl Lysmcre and Atg5fl/fl bone
marrow was provided by Dr. Herbert W. Virgin (Washington
University, Saint Louis).
Ethics Statement
All experiments were conducted according to Cedars-Sinai
Medical Center Institutional Animal Care and Use Committee
(IACUC) guidelines (IACUC# 8314).
CP Infection Model
Chlamydia pneumoniae CM-1 (American Type Culture
Collection, Manassas, VA) was propagated in HEp-2 cells, as
previously described (28). Both HEp-2 cells and C. pneumoniae
aliquots were confirmed as beingMycoplasma- free by PCR.Mice
were infected with either 1× 106 or 2.5× 106 inclusion forming
units (IFU) C. pneumoniae by inoculating intratracheally.
Bronchoalveolar lavage fluid (BALF) was collected by injecting
0.5ml PBS containing 5mM EDTA. BALF was separated into
supernatant and cells by centrifugation. Supernatant was used for
cytokine and chemokine measurements, and cells were analyzed
by Flow Cytometry. In some experiments, mice were injected
with rapamycin (3 mg/kg; ThermoFisher Scientific, MA, USA)
i.p., every other day until sacrifice. The first injection was given
6 h prior to infection.
CP IFU Determination
HEp-2 cells were infected with C. pneumoniae in lung specimens
for bacterial burden quantification, as described previously (29).
Briefly, HEp-2 cells were incubated with diluted lung suspensions
or cell lysates in the presence of RPMI 1640 medium containing
1µg/ml cycloheximide. Centrifugation was performed for 1 h
at 800 x g, and cells were placed in an incubator (37◦C, 0.5%
CO2). After 72 h of culture, cells were washed with PBS,
fixed with methanol, and stained with FITC-conjugated anti-
Chlamydia genus-specific mAb (Pathfinder Chlamydia Culture
Confirmation System; Bio-Rad, Hercules, CA), according to the
manufacturer’s instructions. C. pneumoniae inclusions in cells
were counted by fluorescence microscopic analysis. For in vitro
inclusion quantification, infected cells were directly assessed
using the Pathfinder Chlamydia Culture Confirmation System
as above.
Flow Cytometry
BALF cellular samples were used for Flow cytometry analysis.
Cells were filtered through a 70µm cell strainer (BD Bio-
sciences, San Jose, CA). Erythrocytes were obviated by RBC
Lysis Buffer (eBioscience, San Diego, CA). Single cells were
stained with the following antibodies (Ab)s (Tonbo Biosciences,
San Diego, CA): F4/80 Ab (BM8), CD11c Ab (N418), Ly6G
Ab (1A8), CD11b Ab (M1/70), and CD3 Ab (145-2C11).
For BALF single-cell differentials, cell types were identified as
neutrophils (CD11c− CD11b+ Ly6G+), alveolar macrophages
(AM)s (CD11b+ CD11c+ F4/80+), dendritic cells (CD11c+
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CD11b+ F4/80−), and T cells (CD3+). Flow cytometric analysis
was performed using a CyAn flow cytometer (Beckman Coulter)
and analyzed using FlowJo software (FlowJo LLC, Ashland, OR).
ELISA
The concentration of cytokine in BALF was determined using
an OptEIA Mouse IL-6 ELISA Set (BD Biosciences) and Mouse
IL-12p40, Mouse IFN-γ ELISA Kit (eBioscience), and DuoSet
Mouse MIP-2 (CXCL2) and Mouse KC (CXCL1) (R&D Systems,
Minneapolis, MN). These assays were performed according to
the manufacturers’ instructions. IL-1β in mouse BALF samples
was measured using the U-PLEX Mouse IL-1β Assay (Meso
Scale Diagnostics, Rockville, Maryland) per the manufacturer’s
instructions. The samples were read and analyzed by MSD
QuickPlex SQ120 instrumentation and Workbench 4.0 Software
(Meso Scale Diagnostics, Rockville, Maryland).
Pulmonary Inflammation Scoring
Lungs were fixed in formalin, paraffin embedded and sectioned.
Lung sections were stained with hematoxylin and eosin.
Inflammatory scoring was performed by a blinded pathologist,
scoring 1–4 as previously described (30).
Immunofluorescence
Caspase-1 activity was detected by Fluorochrome-labeled
inhibitors of caspases assay (FLICA) from Immunochemistry
Technologies (Bloomington, MN) per the manufacturer’s
instructions for either frozen sections or live tissue culture.
For Immunofluorescence staining for frozen sections, fixing
and antigen blocking were performed using immunoglobulin
from the species of the secondary antibodies. Next, the sections
were incubated with primary antibodies for 2 h RT, followed by
incubation with appropriate secondary antibodies conjugated
with Fluorescent dyes. For identification of FLICA+ cells, anti-
F4/80 (BM8) antibody and anti CD11c (N418) (eBioscience)
were used.
Bone Marrow Derived Macrophages
(BMDM) and Isolation of
Peritoneal Macrophages
BMDM: Femora and tibiae of 8–10 week old C57BL/6 were
flushed with RPMI 1640 medium. Bone marrow cells were
cultured in RPMI 1640 medium containing 10% FBS and 15%
L929 cell conditioned medium with 2 media changes. BMDM
were harvested on day 7. Elicited peritoneal macrophages: 1ml
thioglycollate media was injected i.p., in mice. 3–4 days later
peritoneal cells were obtained by syringe and plated. Twenty four
hour later, non-adherent cells were washed away.
Statistics
Data are presented as mean ± SEM. For survival studies,
significance was evaluated by the log-rank test. For comparisons
between two groups, statistical significance was evaluated
using Student’s two-tailed unpaired t-test. For non-normally
distributed data, unpaired Mann–Whitney test was used. For
experiments in which more than two samples were analyzed,
one-way ANOVA with the Tukey post-hoc test were used to
assess statistical significance between groups. p < 0.05 was
considered significant.
RESULTS
Autophagy Regulates Chlamydia
pneumoniae Inclusion Formation
In order to understand what role autophagy might play during
CP growth, we infected MEFs with CP and observed that
48 h after infection, most of the LC3 was lipidated (LC3-II),
suggestion an increase in autophagy (Supplemental Figure 1A).
We next infected Atg16l1+/− MEFs and observed a significant
increase in the number of inclusions present when compared
with WT MEFS (Figure 1A). ATG16L1, along with ATG5 and
ATG12, make up the elongation complex of autophagosome
formation (31). By gross observation, the CP inclusions in
Atg16l1+/− MEFs were often much larger than those in WT
MEFS (Supplemental Figure 1). In addition to an increase
in inclusion numbers, Atg16l1+/− cells developed a greater
number of CP progeny as measured by inclusion forming
units (IFU) (Figure 1B). We observed a similar increase
in inclusion numbers as well as progeny in CP infected
bone marrow derived macrophages from Atg16l1fl/fl LysmCre
mice (Figures 1C,D). Surprisingly, we observed the opposite
phenotype when cells were deficient in another autophagy
component, Atg5, as CP-infected Atg5−/− MEFs with CP
had significantly fewer inclusions and progeny than WT cells
(Figures 1E,F). Additionally, the CP inclusions observed in
Atg5−/− MEFs were significantly smaller than those in WT
MEFs (Figure 1G, Supplemental Figure 1B). This discrepancy
between Atg16l1+/− MEFs and Atg5−/− MEFs was surprising
as both ATG16L1 and ATG5 participate in the same autophagic
complex, along with ATG12. However, CP-infected Atg5−/−
macrophages obtained from Atg5fl/fl LysmCre mice displayed
higher inclusion numbers that WT macrophages (Figure 1H),
similar to macrophages lacking ATG16L1. Thus, while it was
clear that autophagic machinery played a role in CP growth
in both MEFs and macrophages, the effect of loss of pathway
components differed between cell types.
Atg5−/− and Atg16l1+/− MEFs Have
Altered Growth Rates Which Affects CP
Inclusion Formation
We next sought to understand why loss of ATG5 and
ATG16L1 had differential effects on CP infection in MEFs.
We observed that Atg16l1+/− MEFs divided much more slowly
than WT MEFs, while Atg5−/− MEFs grew much more quickly
(Figure 2A). We therefore suspected that the difference in CP
inclusion formation between Atg16l1+/− MEFs and Atg5−/−
MEFs may be due to cell growth rates and perhaps nutritional
limits. Indeed, inhibiting cell growth with cycloheximide, which
has also been reported to affect autophagy (32), resulted in a
significant increase in the number and size of inclusions in
Atg5−/− MEFs (Figures 2B,C). An increase was also observed
in WTMEFs treated with cycloheximide. We therefore reasoned
that in nutrient-replete conditions, CP inclusion formation
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FIGURE 1 | Autophagy plays a role during CP growth. (A,B)WT and Atg16l1+/− MEFs were infected with CP (MOI 10) and 68 h later assessed for inclusions (A) and
IFUs (B). (C,D) Atg16l1fl/fl and Atg16l1fl/fl Lysmcre BMDM were infected with CP (MOI 1) and 68 h later assessed for inclusions (C) and IFUs (D). (E–G) WT and
Atg5−/− MEFs were infected with CP (MOI 10) and 68 h later assessed for inclusions (E), IFUs (F), and inclusion size (G). (H) Atg5fl/fl and Atg5fl/fl Lysmcre BMDM
were infected with CP (MOI 1) and 68 h later assessed for inclusions (C). All panels are representative of three experiments. Significance was assessed by students
t-test. **p < 0.01, ***p < 0.001.
may be affected by differential growth rates. To test this, we
seeded tissue culture plates with various starting numbers of
MEFs and infected them with the same CP multiplicity of
infection. Regardless of the starting cell number, Atg16l1+/−
MEFs were able to support high numbers of CP inclusions
(Figure 2D). However, Atg5−/− MEFs could only support
CP inclusion growth at the lowest cell seeding density, and
no inclusions were observed at higher starting cell numbers
(Figure 2D). Similarly, while WT MEFs had greater numbers
of inclusions than Atg5−/− MEFs at lower seeding density, and
they failed to support CP inclusion growth when seeded at high
density (Figure 2D). Finally, when Atg5−/− MEFs were supplied
with additional amino acid supplement and sodium pyruvate,
greater numbers of inclusions were observed (Figure 2E). Taken
together, these data indicate that differential growth rates and
subsequent depletion of nutrients underlies the difference in CP
inclusion formation in Atg16l1+/− and Atg5−/− MEFs, and in
macrophages, where there is little cell growth, loss of ATG5
and ATG16L1 both lead to increased numbers of CP inclusions
and progeny, suggesting that autophagy plays a role in limiting
CP growth.
Autophagy Deficient Mice Are Susceptible
to CP Infection in vivo
We next investigated how the loss of autophagy in phagocytic
cells [macrophages (Supplemental Figure 2A), neutrophils,
dendritic cells (DC)s etc.] would affect CP infection and
clearance in mice. We found that Atg16l1fl/fl LysmCre mice were
significantly more susceptible to CP infection than littermate
Atg16l1fl/fl mice, displaying 100% lethality within 8 days of
infection (Figure 3A). In order to investigate the course of
infection and immune responses, we infected Atg16l1fl/fl LysmCre
and littermateAtg16l1fl/fl controls with a lower inclusion forming
unit (IFU) dose of CP. To our surprise, despite the differences
observed in mortality, the bacterial burden was equivalent
in the lungs of mice with myeloid autophagy deficiency and
controls (Figure 3B). Bronchoalveolar lavage fluid (BALF)
analysis revealed an increase in the number of cells in Atg16l1fl/fl
LysmCre lungs 5 days after infection that resolved by day 9
(Figure 3C). While there were no differences in the numbers
of AMs and T-cells between genotypes (Figures 3D,E), flow
cytometry revealed a significant increase in both neutrophils and
dendritic cells in the BALF of Atg16l1fl/fl LysmCre mice 5 and 9
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FIGURE 2 | CP growth requires adequate nutrition available to the host. (A)WT, Atg16l1+/−, and Atg5−/− MEFs were seeded at 5 × 104 in a 24-well plate. Total cell
numbers were counted after 3 days. (B,C) Atg5−/− MEFs were infected with CP (MOI 10) and treated with 1µg/ml cycloheximide. Inclusions were counted 68 h post
infection (B), as was inclusion size (C). (D) WT, Atg16l1+/−, and Atg5−/− MEFs were seeded at the indicated amounts in a 24-well plate and infected with CP (MOI
10). Inclusions were counted 68 h post infection. (E) Atg5−/− MEFs were infected with CP (MOI 10) and the media was supplemented with either MEM amino acids
(AA), Na-pyruvate (NaPyr), or both. Inclusions were counted 68 h post infection. All panels are representative of three experiments. Data are mean ± SEM.
Significance was assessed by students t-test (B,C) or one-way ANOVA (A,E). *p < 0.05, ***p < 0.001, **** p < 0.0001.
days after infection (Figures 3F,G, Supplemental Figure 2B).
Autophagy deficiency did not alter the levels of the critical
pro-inflammatory cytokines required for normal immune
responses to CP: IFN-γ, IL-6, or IL-12p40 (Figures 3H–J).
However, in support of our finding of increased neutrophils,
neutrophilic chemokines CXCL1 and CXCL2 were elevated in
BALF from Atg16l1fl/fl LysmCre mice compared with controls
(Figures 3K, L). Despite the increase in neutrophils and DCs,
we did not observe a significant difference in gross pathology in
the lungs by H&E between the conditional knockout and control
mice (Supplemental Figure 2C). Thus, loss of autophagy in
myeloid cells led to increased lung infiltration by neutrophils
and DCs in the setting of CP infection and impaired survival but
does not affect CP burden.
Autophagy Deficiency Leads to Increased
Pulmonary Inflammasome Activity and
IL-1β Production in Response to
CP Infection
We previously showed that IL-1β production via the NLRP3
inflammasome is critically required to control CP growth to
successfully resolve the infection in mice (33). Furthermore,
autophagy and mitophagy are known to negatively regulate
the NLRP3 inflammasome and subsequent IL-1β secretion (5–
7). Indeed, Atg16l1fl/fl LysmCre macrophages produced more
IL-1β than controls in response to CP infection (Figure 4A),
which correlated with increased Caspase-1 activity (Figure 4B,
Supplemental Figure 3A).
We next assessed the effect of autophagy deficiency on IL-1
β production in vivo. Atg16l1fl/fl LysmCre mice had significantly
more IL-1β in BALF 1 day after infection compared with control
animals (Figure 4C), corroborating out in vitro data. Finally,
we also assessed Caspase-1 activity in the lungs of CP-infected
mice 1 day post infection. Confirming our in vitro results, lung
sections from Atg16l1fl/fl LysmCre showed significantly more
FLICA positive macrophages compared with littermate controls
(Figure 4D, Supplemental Figure 3B). Interestingly, the FLICA
positive macrophages (F4/80+) that we observed were not
CD11c+ (Supplemental Figure 3C), suggesting that these were
not alveolar macrophages (AMs), but instead of a different origin,
such as interstitial macrophages or newly recruited monocytes.
Additionally, while it does not completely rule out other cell
types secreting IL-1β in this model, we did not observe any non
F4/80+ FLICA+ cells.
Induction of Autophagy Limits CP Growth
in vitro but Not in vivo
Since our data indicated that loss of autophagy in macrophages
led to increased CP growth due to reduced bacterial killing, we
asked whether induction of autophagy by chemical means would
lead to reduced CP inclusion formation. We therefore treated
WT MEFs with tamoxifen, a potent autophagy inducer (34), for
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FIGURE 3 | Loss of autophagy in myeloid cells leads to neutrophilia and mortality during CP infection. (A) Atg16l1fl/fl and Atg16l1fl/fl Lysmcre mice were infected with
2.5 × 106 IFU CP i.t. and mortality was assessed (n = 5–6). (B–L) Atg16l1fl/fl and Atg16l1fl/fl Lysmcre mice were infected with 1.0 × 106 IFU CP i.t. and mice were
sacrificed 3, 5, and 9 days after infection (n = 9–13, pooled from two experiments). (B) Bacterial burden in the lungs. (C) Total cells in the BALF. (D) BALF Alveolar
macrophages. (E) BALF T-cells. (F) BALF neutrophils. (G) BALF DCs. (H) BALF IFN-γ. (I) BALF IL-6. (J) BALF IL-12p40. (K) BALF CXCL1. (L) BALF CXCL2. Data are
mean ± SEM. Significance was assessed by students t-test. Survival curve was compared using the Log-Rank (Mantel-Cox) Test. *p < 0.05, **p < 0.01, ***p < 0.001.
the first 2 h of CP infection, and found that autophagy induction
led to a significant reduction in CP inclusion formation, as well
as progeny (Figures 5A, B). We next assessed whether induction
of autophagy in vivo could rescue mice infected with a high
dose of CP. Mice were i.p., injected with the autophagy inducer
rapamycin (35), 6 h prior to CP infection, and every other
day through the duration of the study. Surprisingly, the mice
receiving rapamycin perished significantly earlier than control
mice (Figure 5C). In order to determine why the rapamycin-
treated mice succumbed to infection more quickly, we repeated
the study with a lower infective dose and sacrificed mice
3 and 6 days after infection. Three days after infection we
observed a reduction in T-cells in the BALF of rapamycin
treated mice, but no changes in DCs, AMs, or neutrophils
(Figures 5D–H). In contrast, while there was a decrease in the
number of AMs 6 days after infection, there was a significant
overall increase in cell counts in the airways primarily due to a
large increase in the number of neutrophils (Figures 5D–H) in
the rapamycin-treated animals. There was no difference in the
bacterial burden at day 3 between control and rapamycin-treated
mice, but there was a significantly greater CP load in the lungs
of rapamycin-treated mice 6 days after infection (Figure 5I).
Since autophagy induction can limit inflammasome activation,
we measured IL-1β in the BALF and found a significant decrease
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FIGURE 4 | Loss of autophagy in myeloid cells leads to an increase in inflammasome activation and IL-1β during CP infection. (A,B) Atg16l1fl/fl and Atg16l1fl/fl
Lysmcre peritoneal macrophages were infected with CP at indicated MOI and (A) IL-1β was measured in the supernatants by ELISA 20 h later. (B) % FLICA positive
cells. (C) IL-1β in BALF 1 day after CP infection in Atg16l1fl/fl and Atg16l1fl/fl Lysmcre mice (n = 9–11 pooled from two separate experiments). (D) Caspase-1 activity
measured by FLICA in frozen lung sections 1 day after CP infection in Atg16l1fl/fl and Atg16l1fl/fl Lysmcre mice (n = 7). Data are mean ± SEM. Significance was
assessed by students t-test. *p < 0.05, **p < 0.01, ***p < 0.001.
in rapamycin-treated mice compared with controls 3 days after
infection (Figure 5J). However, at 6 days after infection we
found a significant increase in IL-1β production. We also found
a clear increase in inflammation in the lungs 6 days after
infection (Figure 5K, Supplemental Figure 4), correlating with
the increase in neutrophils and IL-1β in the BALF, as well as the
greater bacterial burden. We did not observe a difference in lung
pathology 3 days after infection (data not shown). Taken together,
these data indicate that the rapamycin-treated mice had greater
mortality due to increased inflammation as a consequence of the
greater bacterial load, likely as a result of the initial reduction in
IL-1β production.
DISCUSSION
Our data investigating the role of autophagy during CP infection
highlights the delicate balance in biological systems. This is
not surprising considering the pathways investigated here and
their relative importance toward immune responses. While our
in vitro experiments demonstrate the key role that autophagy
plays in controlling CP inclusion formation and bacterial growth,
the overall balance in vivo is much more complex. Loss of
autophagy in myeloid cells led to increased mortality during CP
infection, but not due to increased bacterial burden. Instead,
we observed a sustained increase in neutrophil recruitment
to the lungs, with a corresponding increase in neutrophilic
chemokines. Importantly, this was accompanied by an increase
in inflammasome positive macrophages in the lung and greater
IL-1β production. This sustained excess inflammation was the
likely driver of excess mortality. While induction of autophagy
in vitro limited CP growth, rapamycin treatment in vivo during
CP infection increased mortality of WT mice, likely due to the
reduction in early IL-1β production leading to an increase in
bacterial burden, followed by increased IL-1β and neutrophil
recruitment. IL-1β is a critical cytokine in controlling CP
infection (33), yet can also be a powerful driver of pathology (36).
Thus, since autophagy antagonizes inflammasome activation, any
perturbation of these pathways during CP infection seems to
result in a worsened outcome, creating a Goldilocks situation in
which the level of autophagy and inflammasome activation must
be perfectly balanced to eliminate the infection.
Common to both scenarios in which CP infected mice had
reduced survival was an increase in neutrophil recruitment.
CXCL1 and CXCL2 were both elevated in infected Atg16l1fl/fl
Lysmcre mice, likely as a result of increased IL-1β signaling (37).
Pulmonary neutrophilia is often associated with pathology and
more recent studies have found that neutrophil extracellular
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FIGURE 5 | Autophagy induction fails to rescue mice from CP infection. WT MEFs were infected with CP (MOI 10) and treated with 10µM Tamoxifen during the first
2 h of infection. (A) CP inclusions. (B) CP progeny. (C) C57Bl/6 mice were infected with 2 × 106 IFU CP. Six hour prior to infection, mice received either sham or 3
mg/kg rapamycin i.p., and again every other day. Mortality was assessed (n = 5–9). (D–J) C57Bl/6 mice were infected with 1 × 106 IFU CP. Six hour prior to infection,
mice received either sham or 3 mg/kg rapamycin i.p., and again every other day (n = 8–12, pooled from two separate experiments). Mice were sacrificed on days 3,
6. (D) Total cells in the BALF. (E) BALF Alveolar macrophages. (F) BALF neutrophils. (G) BALF DCs. (H) BALF T-cells. (I) Bacterial burden in the lungs. (J) IL-1β in the
BALF after CP infection and rapamycin treatment. (K) Lung inflammation score on day 6. Significance was assessed by students t-test. Survival curves was
compared using the Log-Rank (Mantel-Cox) Test. Data are mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
traps can also lead to enhanced tissue damage (38). While we
did not assess this in our model, this could be a mechanism
by which pulmonary damage leads to decreased survival. We
also observed an increase in DC recruitment to the lungs in CP
infected Atg16l1fl/fl Lysmcre mice, but this did not lead to an
increased T-cell presence in the lung.
The process of recycling cellular components and removal
of damaged organelles has been found to play critical roles in
a wide variety of diseases and cellular responses. Importantly,
in the setting of bacterial infections, autophagy can be
either beneficial and detrimental to the host. In multiple
infections, such as S. typhimurium, Pseudomonas aeruginosa,
or M. tuberculosis, loss of autophagy led to reduced bacterial
clearance and subsequent enhanced pathology (13, 39, 40). In
contrast, we showed that despite a clear role for autophagy
in limiting CP growth in vitro, loss of autophagy in vivo did
not impair bacterial clearance. This difference is likely due
to the enhanced IL-1β production observed in CP-infected
autophagy impaired mice, as CP is exquisitely sensitive to IL-
1β (33).
While the development of novel antibiotics is one approach
to combating the ever increasing number of resistant strains
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of bacteria, other mechanisms of enhancing bacterial clearance
have also been investigated. Given that, in many cases, autophagy
induction can help cells eliminate intracellular infections,
several studies have investigated the antibacterial potential of
autophagy induction. Supporting this effect, it has been shown
that rapamycin given prophylactically in the drinking water
before P. aeruginosa lung infection significantly reduced the
bacterial burden (41), and that rapamycin treatment given
i.p., reduced Leishmania parasite load (42). However, we
found here that rapamycin treatment during CP infection
actually increased CP burden and mortality. One possibility
for these differing results may be the particular sensitivity
of CP to IL-1β, such that the rapamycin-induced initial
reduction in IL-1β resulted in enhanced CP overgrowth
followed by subsequent immune-derived pathology. Perhaps
a selective autophagy inducer that did not affect mitophagy
and inflammasome activation might have a more beneficial
outcome. Additionally, rapamycin is known to suppress T-
cell responses and neutrophil extracellular traps (43, 44),
which could also impair bacterial clearance in this model.
Regardless, these investigations make clear that the antibacterial
effects of autophagy induction are context- and pathogen-
dependent.
Activation of the NLRP3 inflammasome involves damage
to the mitochondria in the presence of NF-κB signaling (6,
45). Damaged mitochondria are sensed by various cellular
pathways and mitophagy is induced to clear them. This,
in effect, leads to a reduction in inflammasome activity,
and thus the manipulation of mitophagy with inducers and
inhibitors directly affects inflammasome activity and IL-1β
production (7, 46). We observed that disrupted autophagy in
macrophages led to enhanced IL-1β secretion by CP infected
macrophages in vitro and more IL-1β found in BALF of CP-
infected mice in vivo. ATG7 deficiency in mice has similarly
been shown to lead to increased IL-1β production during P.
aeruginosa infection (47). However, in contrast to CP infection,
autophagy disruption resulted in increased bacterial CFU in
that study, corroborating earlier work showing that loss of IL-
1β leads to a reduction in bacterial burden and that enhanced
inflammation is beneficial to P. aeruginosa growth in the
lung (48). In contrast, the loss of autophagy may lead to
excessive IL-1β production and enhanced pathology (36), as in
our CP study.
In many instances, intracellular bacterial infections
manipulate or require components of the autophagy
machinery to successfully infect host cells. After invading
host cells, Staphylococcus aureus grows in double membraned
autophagosomes which do not fuse with the lysosomalmachinery
(20). Similarly, Yersinia pestis can prevent acidification of the
autophagosome, thereby preventing xenophagy (16). In other
instances, bacteria can utilize specific components of the
autophagy machinery to form the intracellular niche in which
they can replicate. For example, Brucella abortus requires
ATG14L, Beclin 1, and ULK1 to form the vacuole where it
replicates (49). However, while CP grows inside a protected
inclusion, loss of either ATG16L1 or ATG5 did not affect CP
growth and instead led to enhanced inclusion formation and
CP replication. However, as ATG16L1 and ATG5 are part of the
same elongation complex in autophagosome development, it is
possible that other parts of the autophagy pathway are required
for CP inclusion formation.
In this study we investigated the role of autophagy during
a pulmonary CP infection. While impairing autophagy limited
intracellular CP growth in vitro, in vivo studies demonstrated that
loss of autophagy in myeloid cells increased mortality, likely due
to the complex antagonistic interplay between the inflammasome
and autophagy. All these data suggest that, at least for some
infections such as CP, any perturbation to the delicate balance
between inflammasome activation and IL-1β secretion can have
negative results. However, given the highly distinctive nature of
bacterial pathogens, understanding each infection separately is
required to fully appreciate how modulating the system would
affect the end result.
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